Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Hematologic Oncology Update
00:00
Epcoritamab in Relapsed/Refractory FL
Matt describes epcoritamab's use for clinically transforming FL and considerations about continuous therapy versus stopping in CR.
Play episode from 12:24
Transcript
